D. Könning, S. Zielonka, J. Grzeschik, M. Empting, B. Valldorf et al., Camelid and shark single domain antibodies: structural features and therapeutic potential, Curr Opin Struct Biol, vol.45, pp.10-16, 2017.

M. F. Flajnik, N. Deschacht, and S. Muyldermans, A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?, PLoS Biol, vol.9, 2011.

A. S. Greenberg, D. Avila, M. Hughes, A. Hughes, E. C. Mckinney et al., A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks, Nature, vol.374, pp.168-73, 1995.

C. Hamers-casterman, T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers et al., Naturally occurring antibodies devoid of light chains, Nature, vol.363, pp.446-454, 1993.

C. Enever, T. Batuwangala, C. Plummer, and A. Sepp, Next generation immunotherapeutics-honing the magic bullet, Curr Opin Biotechnol, vol.20, pp.405-416, 2009.

L. Detalle, T. Stohr, C. Palomo, P. A. Piedra, B. E. Gilbert et al., Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection, Antimicrob Agents Chemother, vol.60, pp.6-13, 2016.

J. Wesolowski, V. Alzogaray, J. Reyelt, M. Unger, K. Juarez et al., Single domain antibodies: promising experimental and therapeutic tools in infection and immunity, Med Microbiol Immunol, vol.198, pp.157-74, 2009.
DOI : 10.1007/s00430-009-0116-7
URL : https://link.springer.com/content/pdf/10.1007%2Fs00430-009-0116-7.pdf

Y. Yu, J. Li, X. Zhu, X. Tang, Y. Bao et al., Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential, Int J Nanomedicine, vol.12, pp.1969-83, 2017.
DOI : 10.2147/ijn.s127575
URL : https://doi.org/10.2147/ijn.s127575

M. Lauwereys, Potent enzyme inhibitors derived from dromedary heavy-chain antibodies, EMBO J, vol.17, pp.3512-3532, 1998.
DOI : 10.1093/emboj/17.13.3512
URL : http://emboj.embopress.org/content/17/13/3512.full.pdf

P. Holliger and P. J. Hudson, Engineered antibody fragments and the rise of single domains, Nat Biotechnol, vol.23, pp.1126-1162, 2005.

E. Conrath, K. Lauwereys, M. Wyns, L. Muyldermans, and S. , Camel singledomain antibodies as modular building units in bispecific and bivalent antibody constructs, Microb Cell Factories, vol.276, pp.7346-50, 2001.

S. Y. Shi, Y. Lu, Z. Liu, J. Stevens, C. M. Murawsky et al., A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity, J Biol Chem, vol.293, pp.5909-5928, 2018.
DOI : 10.1074/jbc.ra118.001752
URL : http://europepmc.org/articles/pmc5912448?pdf=render

B. Laventie, H. J. Rademaker, M. Saleh, E. De-boer, R. Janssens et al., Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins, Proc Natl Acad Sci, vol.108, pp.16404-16413, 2011.
DOI : 10.1073/pnas.1102265108
URL : https://www.pnas.org/content/pnas/108/39/16404.full.pdf

C. Vincke, R. Loris, D. Saerens, S. Martinez-rodriguez, S. Muyldermans et al., General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold, J Biol Chem, vol.284, pp.3273-84, 2009.

C. Mcmahon, A. S. Baier, R. Pascolutti, M. Wegrecki, S. Zheng et al., Yeast surface display platform for rapid discovery of conformationally selective nanobodies, Nat Struct Mol Biol, vol.25, pp.289-96, 2018.

R. Janssens, S. Dekker, R. W. Hendriks, G. Panayotou, A. V. Remoortere et al., Generation of heavy-chain-only antibodies in mice, Proc Natl Acad Sci, vol.103, pp.15130-15135, 2006.

X. Fu, X. Gao, S. He, D. Huang, P. Zhang et al., Design and selection of a camelid single-chain antibody yeast two-hybrid library produced de novo for the cap protein of porcine circovirus type 2 (PCV2), PLoS ONE, vol.8, 2013.

M. Kovaleva, L. Ferguson, J. Steven, A. Porter, and C. Barelle, Shark variable new antigen receptor biologics -a novel technology platform for therapeutic drug development, Expert Opin Biol Ther, vol.14, pp.1527-1566, 2014.

P. Chames, M. Van-regenmortel, E. Weiss, and D. Baty, Therapeutic antibodies: successes, limitations and hopes for the future, Br J Pharmacol, vol.157, pp.220-253, 2009.

Z. Lu, Frontier of therapeutic antibody discovery: the challenges and how to face them, World J Biol Chem, vol.3, p.187, 2012.

K. E. Harris, S. F. Aldred, L. M. Davison, H. Ogana, A. Boudreau et al., Sequence-based discovery demonstrates that fixed light chain human transgenic rats produce a diverse repertoire of antigen-specific antibodies, Front Immunol, vol.9, p.889, 2018.

A. Walker, C. Chung, M. Neu, M. Burman, T. Batuwangala et al., Novel interaction mechanism of a domain antibody-based inhibitor of human vascular endothelial growth factor with greater potency than ranibizumab and bevacizumab and improved capacity over aflibercept, J Biol Chem, vol.291, pp.5500-5511, 2016.

S. Ewert, T. Huber, A. Honegger, and A. Plückthun, Biophysical properties of human antibody variable domains, J Mol Biol, vol.325, pp.531-53, 2003.

J. Davies and L. Riechmann, Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability, Protein Eng Des Sel, vol.9, pp.531-538, 1996.

R. Rouet, K. Dudgeon, M. Christie, D. Langley, and D. Christ, Fully human V H single domains that rival the stability and cleft recognition of camelid antibodies, J Biol Chem, vol.290, pp.11905-11922, 2015.

K. Lou, Crescendo's TKO. Sci-Bus Exch, vol.3, pp.1227-1254, 2010.

A. M. Geurts, G. J. Cost, Y. Freyvert, B. Zeitler, J. C. Miller et al., Knockout rats via embryo microinjection of zinc-finger nucleases, Science, vol.325, p.433, 2009.
DOI : 10.1126/science.1172447
URL : http://europepmc.org/articles/pmc2831805?pdf=render

M. J. Osborn, B. Ma, A. S. Binnie, A. Dilley, J. Yang et al., High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Ig /Ig loci bearing the rat CH region, J Immunol, vol.190, pp.1481-90, 2013.

S. Ménoret, A. Iscache, L. Tesson, S. Rémy, C. Usal et al., Characterization of immunoglobulin heavy chain knockout rats, Eur J Immunol, vol.40, pp.2932-2973, 2010.

B. Ma, M. J. Osborn, A. S. Ouisse, L. Ménoret, S. Anegon et al., Human antibody expression in transgenic rats: comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions, J Immunol Methods, pp.400-401, 2013.

E. Kabat, T. Wu, H. Bilofsky, M. Reid-miller, and H. Perry, Sequences of Proteins of Immunological Interest. Bethesda: US Department of Health and Human Services and the National Institute Health Bethesda, 1987.

P. A. Barthelemy, H. Raab, B. A. Appleton, C. J. Bond, P. Wu et al., Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human V H domains, J Biol Chem, vol.283, pp.3639-54, 2008.

V. Giudicelli, D. Chaume, M. Lefranc, . Imgt, and . Gene-db, a comprehensive database for human and mouse immunoglobulin and T cell receptor genes, Nucleic Acids Res, vol.33, pp.256-257, 2005.
DOI : 10.1093/nar/gki010
URL : https://academic.oup.com/nar/article-pdf/33/suppl_1/D256/7621450/gki010.pdf

I. Van-dijk-hard and I. Lundkvist, Long-term kinetics of adult human antibody repertoires, Immunology, vol.107, pp.136-180, 2002.

H. Brezinschek, S. J. Foster, R. I. Brezinschek, T. Dörner, R. Domiati-saad et al., Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells, J Clin Invest, vol.99, pp.2488-501, 1997.

K. A. Henry, D. Y. Kim, H. Kandalaft, M. J. Lowden, Q. Yang et al., Stability-diversity tradeoffs impose fundamental constraints on selection of synthetic human VH/VL single-domain antibodies from in vitro display libraries. Front Immunol, vol.8, p.1759, 2017.

M. L. Brader, T. Estey, S. Bai, R. W. Alston, K. K. Lucas et al., Examination of Thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies, Mol Pharm, vol.12, pp.1005-1022, 2015.

K. Conrath, C. Vincke, B. Stijlemans, J. Schymkowitz, K. Decanniere et al., Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to Mimic a VH, J Mol Biol, vol.350, pp.112-137, 2005.

R. Rouet, D. Lowe, and D. Christ, Stability engineering of the human antibody repertoire, FEBS Lett, vol.588, pp.269-77, 2014.

X. Zou, M. J. Osborn, D. J. Bolland, J. A. Smith, D. Corcos et al., Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice, J Exp Med, vol.204, pp.3271-83, 2007.
DOI : 10.1084/jem.20071155
URL : http://jem.rupress.org/content/204/13/3271.full.pdf

G. Bianchi, K. C. Anderson, N. L. Harris, and A. R. Sohani, The heavy chain diseases: clinical and pathologic features, Oncol Williston Park N, vol.28, pp.45-53, 2014.

J. Davies and L. Riechmann, Camelising" human antibody fragments: NMR studies on VH domains, FEBS Lett, vol.339, pp.285-90, 1994.

J. Nilvebrant, P. Tessier, and S. Sidhu, Engineered autonomous human variable domains, Curr Pharm Des, vol.22, pp.6527-6564, 2017.
DOI : 10.2174/1381612822666160921143011
URL : http://europepmc.org/articles/pmc5326600?pdf=render

E. M. Scherer, R. A. Smith, D. F. Gallego, J. J. Carter, G. C. Wipf et al., A single human papillomavirus vaccine dose improves b cell memory in previously infected subjects, EBioMedicine, vol.10, pp.55-64, 2016.

M. Matz, D. Shagin, E. Bogdanova, O. Britanova, S. Lukyanov et al., Amplification of cDNA ends based on templateswitching effect and step-out PCR, Nucleic Acids Res, vol.27, pp.1558-60, 1999.

M. S. Son and R. K. Taylor, Preparing DNA libraries for multiplexed paired-end deep sequencing for Illumina GA sequencers, Curr Protoc Microbiol, 2011.
DOI : 10.1002/9780471729259.mc01e04s20
URL : http://europepmc.org/articles/pmc3076644?pdf=render

D. Jung, C. Giallourakis, R. Mostoslavsky, and F. W. Alt, Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus, Annu Rev Immunol, vol.24, pp.541-70, 2006.

J. Bürckert, A. Dubois, W. J. Faison, S. Farinelle, E. Charpentier et al., Functionally convergent b cell receptor sequences in transgenic rats expressing a human B cell repertoire in response to tetanus toxoid and measles antigens, Front Immunol, vol.8, p.1834, 2017.

W. Kabsch and . Xds, Acta Crystallogr D Biol Crystallogr, vol.66, pp.125-157, 2010.

A. J. Mccoy, R. W. Grosse-kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni et al., Phaser crystallographic software, J Appl Crystallogr, vol.40, pp.658-74, 2007.

P. Emsley and K. Cowtan, Coot: model-building tools for molecular graphics, Acta Crystallogr D Biol Crystallogr, vol.60, pp.2126-2158, 2004.
DOI : 10.1107/s0907444904019158
URL : http://journals.iucr.org/d/issues/2004/12/01/ba5070/ba5070.pdf

G. N. Murshudov, P. Skubák, A. A. Lebedev, N. S. Pannu, R. A. Steiner et al., REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr D Biol Crystallogr, vol.67, pp.355-67, 2011.

M. A. Larkin, G. Blackshields, N. P. Brown, R. Chenna, P. A. Mcgettigan et al., Clustal W and clustal X version 2.0, Bioinforma Oxf Engl, vol.23, pp.2947-2955, 2007.
DOI : 10.1093/bioinformatics/btm404
URL : https://hal.archives-ouvertes.fr/hal-00206210

D. Eisenberg, E. Schwarz, M. Komaromy, and R. Wall, Analysis of membrane and surface protein sequences with the hydrophobic moment plot, J Mol Biol, vol.179, pp.125-167, 1984.

E. Gasteiger, A. Gattiker, C. Hoogland, I. Ivanyi, R. D. Appel et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res, vol.31, pp.3784-3792, 2003.

J. Kyte and R. F. Doolittle, A simple method for displaying the hydropathic character of a protein, J Mol Biol, vol.157, pp.105-137, 1982.